Xiangyang Chen Selected Research

Xiangyang Chen Research Topics

Disease

6	Heart Failure 01/2023 - 01/2019
4	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 01/2019
3	Infections 01/2023 - 01/2021
3	Inflammation (Inflammations) 01/2022 - 05/2017
2	Stroke (Strokes) 01/2023 - 01/2021
2	Neoplasms (Cancer) 01/2023 - 01/2020
2	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2021
2	Body Weight (Weight, Body) 01/2023 - 01/2021
2	Fibrosis (Cirrhosis) 12/2020 - 07/2020
2	Cardiomegaly (Heart Hypertrophy) 01/2019 - 01/2019
1	Classical Swine Fever (Swine Fever) 01/2024
1	Pancreatitis 12/2023
1	Lung Injury 12/2023
1	Chronic Renal Insufficiency 01/2023
1	Myocardial Infarction 01/2023
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2023
1	Genomic Instability 01/2023
1	Hyperglycemia 12/2022
1	Acute Kidney Injury (Acute Renal Failure) 12/2022
1	Cardiogenic Shock 12/2022
1	Starvation 10/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021
1	Neuralgia (Stump Neuralgia) 01/2021
1	Eye Diseases (Eye Disease) 01/2021
1	Rotator Cuff Injuries 01/2021
1	Bursitis (Adhesive Capsulitis) 01/2021
1	Blindness (Hysterical Blindness) 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	COVID-19 12/2020
1	Critical Illness (Critically Ill) 12/2020
1	Hypertrophy 12/2020
1	Insulin Resistance 12/2020
1	Ventricular Remodeling 07/2020
1	Femoral Neck Fractures 06/2020
1	Necrosis 06/2020
1	Vascular Remodeling 06/2020
1	Carcinogenesis 01/2020
1	Wounds and Injuries (Trauma) 07/2019
1	Hemorrhage 07/2019
1	Postoperative Hemorrhage 07/2019

Drug/Important Bio-Agent (IBA)

3	Messenger RNA (mRNA)IBA 12/2023 - 01/2019
3	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 06/2020
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2022
3	si-miao-yong-an decoctionIBA 07/2020 - 01/2019
2	LipopolysaccharidesIBA 12/2023 - 01/2022
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2023 - 01/2021
2	SodiumIBA 01/2023 - 01/2021
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2023 - 01/2021
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2023 - 01/2021
2	Blood Glucose (Blood Sugar)IBA 12/2022 - 12/2020
2	Piwi-Interacting RNAIBA 10/2022 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2022 - 12/2020
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 07/2019
2	CollagenIBA 07/2020 - 01/2019
2	Atrial Natriuretic Factor (ANF)IBA 01/2019 - 01/2019
1	VaccinesIBA 01/2024
1	Biomarkers (Surrogate Marker)IBA 12/2023
1	MicroRNAs (MicroRNA)IBA 12/2023
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	Histones (Histone)IBA 01/2023
1	Mineralocorticoid Receptor AntagonistsIBA 01/2023
1	methyl-lysineIBA 01/2023
1	Insulin (Novolin)FDA Link 01/2023
1	ThiazolidinedionesIBA 01/2023
1	ChromatinIBA 01/2023
1	tirzepatideIBA 01/2023
1	finerenoneIBA 01/2023
1	Spliced Leader RNA (Spliced Leader)IBA 10/2022
1	Small Nuclear RNA (snRNA)IBA 10/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022
1	ProteomeIBA 01/2022
1	Sodium-Glucose Transport ProteinsIBA 01/2021
1	Methylprednisolone FDA LinkGeneric 12/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2020
1	LipidsIBA 12/2020
1	Matrix Metalloproteinases (MMPs)IBA 07/2020
1	AcidsIBA 06/2020
1	Retroelements (Retrotransposon)IBA 01/2020
1	ButadienesIBA 01/2020
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2020
1	Tranexamic Acid (AMCA)FDA Link 07/2019
1	salicylhydroxamic acid (SHAM)IBA 01/2019
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 01/2019
1	Wheat Germ AgglutininsIBA 01/2019
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019
1	Hematoxylin (Haematoxylon)IBA 01/2019
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2019
1	Carboxylic AcidsIBA 08/2010

Therapy/Procedure

2	Therapeutics 01/2021 - 12/2020
1	Cardiopulmonary Resuscitation (CPR) 12/2022
1	Conservative Treatment 01/2021
1	Surgical Amputation (Amputations) 01/2021
1	Art Therapy 01/2021
1	Sutures (Suture) 01/2021
1	Fracture Fixation 06/2020
1	Aftercare (After-Treatment) 06/2020
1	Knee Replacement Arthroplasty (Total Knee Replacement) 07/2019
1	Blood Transfusion (Blood Transfusions) 07/2019
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 05/2017